Assessing bioequivalence of generic anti
β
Gregory L. Krauss; Brian Caffo; Yi-Ting Chang; Craig W. Hendrix; Kelly Chuang
π
Article
π
2011
π
John Wiley and Sons
π
English
β 788 KB
## Objective: Patients with epilepsy are often concerned that switching between brand-name and generic formulations of antiepilepsy drugs (aeds) may cause clinically significant changes in plasma drug concentrations. we assessed bioequivalence (be) studies for approved generic aeds to evaluate us f